Evidence map›Paper›PMID 40810879›Full record

ArticleAIDS and behavior2026

PrEP and PEP for HIV Prevention Among Gay, Bisexual, and MSM in Brazil: Findings from the SMESH Study.

Ben Hur Graboski Pinheiro, Thayane Martins Dornelles, Gustavo Eidt, Emerson Silveira de Brito, Rafael Steffens Martins, Giovana Petracco de Miranda, Natalia Luiza Kops, Suelen Porto Basgalupp, Flávia Moreno Alves de Souza, Gerson Fernando Mendes Pereira and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ben Hur Graboski PinheiroUniversidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0003-2414-8846
Thayane Martins DornellesUniversidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0001-7377-7054
Gustavo EidtHospital Moinhos de Vento, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-9813-5995
Emerson Silveira de BritoHospital Moinhos de Vento, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-6153-2970
Rafael Steffens MartinsHospital Moinhos de Vento, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-4817-9789
Giovana Petracco de MirandaUniversidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-3220-6172
Natalia Luiza KopsHospital Moinhos de Vento, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-3807-182X
Suelen Porto BasgaluppHospital Moinhos de Vento, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-3274-8801
Flávia Moreno Alves de SouzaDepartamento de HIV/AIDS, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis (Dathi) do Ministério da Saúde, Brasília, DF, Brazil.ORCID http://orcid.org/0000-0001-8892-1661
Gerson Fernando Mendes PereiraDepartamento de HIV/AIDS, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis (Dathi) do Ministério da Saúde, Brasília, DF, Brazil.ORCID http://orcid.org/0000-0001-8886-1662
Maiko Luis ToniniDepartamento de HIV/AIDS, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis (Dathi) do Ministério da Saúde, Brasília, DF, Brazil.ORCID http://orcid.org/0000-0002-3705-9802
Eliana Marcia WendlandUniversidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. elianawend@gmail.com.ORCID http://orcid.org/0000-0001-6356-6413

Funding

Program for Institutional Development of the Unified Healthcare System 25000.012591/2021-21
6 · The paper itself

Abstract

The HIV epidemic remains a global concern, particularly among vulnerable populations. Effective strategies, such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), are crucial to reducing HIV transmission. This study assessed HIV prophylaxis use among men who have sex with men (MSM) in Brazil, examined associated factors, and evaluated perceptions regarding access through the public healthcare system (SUS). A cross-sectional study (2019-2023) was conducted using respondent-driven sampling (RDS) in ten state capitals across five Brazilian regions. Eligible participants were men aged ≥ 18 years, identifying as MSM, who reported oral or anal sex with another man in the past 12 months. Data were collected via structured questionnaires on socio-behavioral characteristics. Descriptive analyses used RDS-II estimators, and associations with prophylaxis use were examined using survey-weighted Poisson regression. Among 1,139 participants, 21.4% reported PrEP use and 20.5% reported PEP use. PrEP uptake was significantly lower among individuals identifying as pardo (PR = 0.58 [95% CI 0.36-0.92]), with no significant associations found for education or social class. Both PrEP and PEP use were positively associated with having more than five sexual partners in the past six months and with having a partner living with HIV. Notably, 86.3% of participants (95% CI 81.1-91.6) expressed willingness to access PrEP through SUS. Despite high willingness, PrEP uptake remains suboptimal, particularly among pardo MSM. These findings underscore the urgency of targeted public policies to expand equitable access to HIV prevention services in Brazil.

Indexed as

HIV InfectionsHomosexuality, MalePost-Exposure ProphylaxisPre-Exposure ProphylaxisSexual and Gender MinoritiesAdolescentAdultAnti-HIV AgentsBrazilCross-Sectional StudiesHealth Services AccessibilityHumansMaleMiddle AgedSexual PartnersSurveys and QuestionnairesAnti-HIV AgentsHIVPost-exposure prophylaxisPre-exposure prophylaxisSexual and gender minorities

Identifiers

PMID40810879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.